3E - Lysosomal Disorders: Models for Common Diseases in Personalized Medicine
CME (AMA PRA Category 1 Credits™) 1.5; CEU (NSGC Category 1) 0.15; Attendance CEU 1.5

Tuesday, October 10
10:15 AM - 11:45 AM

During this session, speakers will focus on the biology of lysosomes and their relevance and understand the current options for diagnosis and management of lysosomal diseases. The session will also explain the integrated resources available at Mayo Clinic for the diagnosis, management and research relating to people with lysosomal disorders.

Learning Objectives:

Marc C. Patterson

Neurology, Professor of Medical Genetics, Neurology, and Pediatrics
Mayo Clinic

Marc Patterson was born and educated in Australia, and trained in neurology, child neurology and neurometabolic disease at the University of Queensland, at Mayo Clinic, and at NINDS/NIH, the last mentioned under the guidance of Roscoe Brady, MD. He is currently Professor of Neurology, Pediatrics and Medical Genetics. He was Director of the Child Neurology Training program at Mayo 2008-2016), and Chair of the Division of Child and Adolescent Neurology (2008-2017); he had previously served as Professor and Director of Pediatric Neurology at Columbia University in New York (2001-2007). He has served as a member of the Neurology topic advisory group for revision of the ICD-10 of the World Health Organization, the Committee on Adverse Effects of Vaccines for the Institute of Medicine, and leads the Education Core of the NIH-funded Lysosomal Disease Network.

He has served in a number of positions in the Child Neurology Society, American Academy of Neurology, American Board of Psychiatry and Neurology and American Neurological Association. Professor Patterson has served on the editorial board of Neurology, on the oversight committee of Annals of Neurology and is currently an Editor for the Journal of Inherited Metabolic Disease. He became Editor-in Chief of the Journal of Child Neurology on January 1st, 2014, and subsequently Editor-in-Chief of its open-access sister journal, Child Neurology Open.

His research and practice has focused on rare diseases in children, including multiple sclerosis and neurometabolic disorders in general, with special interests in Niemann-Pick disease, type C, other lysosomal diseases (including glycoproteinoses), mitochondrial cytopathies and congenital disorders of glycosylation, areas in which he has published more than 200 peer-reviewed papers and book chapters. He has presented widely through the United States and internationally, both to professional and lay organizations. Dr Patterson has received funding support from NIH, industry and private foundations.

Presentation(s):

Send Email for Marc Patterson

Send Email for Mark McNiven

Dietrich Matern

Chair, Division of Laboratory Genetics and Genomics
Mayo Clinic

Dietrich Matern, MD, PhD, is a Professor of Laboratory Medicine, Medical Genetics and Pediatrics, and serves as Chair of Mayo Clinic's Division of Laboratory Genetics and Genomics, as well as co-director of Mayo Clinic's Biochemical Genetics Laboratory. He has a primary interest in the biochemical diagnosis of inborn errors of metabolism, particularly lysosomal storage disorders, mitochondrial fatty acid beta-oxidation disorders, organic acidemias, amino acidopathies, and glycogen storage disorders. Dr. Matern's research activities involve the development and improvement of laboratory assays for the effective and efficient screening, diagnosis and follow-up of patients with inborn errors of metabolism. A particular focus in recent years has been on newborn screening for several lysosomal storage disorders, X-adrenoleukodystrophy, Friedreich ataxia and Wilson disease. He has also participated in the laboratory evaluation of animal models and clinical trials as a collaborator with colleagues at Mayo Clinic and other academic institutions. He authored or co-authored more than 130 peer-reviewed publications and 18 textbook chapters. Dr. Matern's research has been funded by the National Institute of Child Health & Human Development (NICHD), the Newborn Screening Translational Research Network (NBSTRN), the Legacy of Angels Foundation, and other not-for-profit organizations.

Presentation(s):

Send Email for Dietrich Matern


Assets

3E - Lysosomal Disorders: Models for Common Diseases in Personalized Medicine
CME (AMA PRA Category 1 Credits™) 1.5; CEU (NSGC Category 1) 0.15; Attendance CEU 1.5



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Lysosomal Disorders: Models for Common Diseases in Personalized Medicine
CME (AMA PRA Category 1 Credits™) 1.5; CEU (NSGC Category 1) 0.15; Attendance CEU 1.5